Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter

被引:7
|
作者
Wang, Jian [1 ]
Zhang, Hui [1 ]
Liang, Rui-Xia [1 ]
Pang, Bo [1 ]
Shi, Qing-Guo [1 ]
Huang, Pei-Tang [1 ]
Huang, Cui-Fen [1 ]
Zhou, Jian-Guang [1 ]
机构
[1] Beijing Inst Biotechnol, Beijing 100850, Peoples R China
关键词
PC-1; gene; promoter; prostate cancer; gene therapy;
D O I
10.1016/j.bbrc.2007.02.153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human prostate and colon gene-1 (PC-1, also known as PrLZ) is an androgen-regulated, prostate tissue and prostate cancer cells specifically expressed novel gene. The increased expression of PC-1 gene appears to promote prostate cancer cells androgen-dependent (AD) and androgen-independent (AI) growth. To clone and investigate the expression and regulation elements of PC-1 gene may provide insight into the function of PC-1 and develop a new promoter that targets therapeutic genes to the AD and AI prostate cancer cells. The goal of the present study is cloning and characterization of the PC-1 promoter. A series of luciferase constructs that contain various fragments of the PC-1 5'-genomic region were transfected into human prostate cancer cells for promoter transactivation analysis. 5' deletion analysis identified the -1579 bp promoter region was required for the maximal proximal promoter activity; two transcriptional suppression and a positive regulatory region were identified; -4939 bp promoter fragment of the PC-1 gene retained the characteristic of prostate cancer-specific expression and exhibited higher transcription activity than PSA-6 kb promoter in the medium supplemented with steroid-depleted FBS. An androgen response element (ARE) was located in between -345 and -359 bp of the PC-1 5'-untranslated region relative to the translation initiation site. Thus, our studies not only provide molecular basis of PC-1 transcription regulation, but also define a new regulatory sequence that may be used to restrict expression of therapeutic genes to prostate cancer in the prostate cancer gene therapy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 50 条
  • [1] Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells
    Moritz, Tom
    Venz, Simone
    Junker, Heike
    Kreuz, Sarah
    Walther, Reinhard
    Zimmermann, Uwe
    TUMOR BIOLOGY, 2016, 37 (08) : 10435 - 10446
  • [2] Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter
    Liu, J
    Zou, WG
    Lang, MF
    Luo, J
    Sun, LY
    Wang, XN
    Qian, QJ
    Liu, XY
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (03) : 661 - 666
  • [3] Identification and characterization of the human parkin gene promoter
    West, A
    Farrer, M
    Petrucelli, L
    Cookson, M
    Lockhart, P
    Hardy, J
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 (05) : 1146 - 1152
  • [4] Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1
    Choi, Ji Ha
    Yee, Sook Wah
    Kim, Mee J.
    Nguyen, Loan
    Lee, Jeong Ho
    Kang, Ji-One
    Hesselson, Stephanie
    Castro, Richard A.
    Stryke, Doug
    Johns, Susan J.
    Kwok, Pui-Yan
    Ferrin, Thomas E.
    Lee, Min Goo
    Black, Brain L.
    Ahituv, Nadav
    Giacomini, Kathleen M.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (10) : 770 - 780
  • [5] Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
    Gotoh, A
    Ko, SC
    Shirakawa, T
    Cheon, J
    Kao, CH
    Miyamoto, T
    Gardner, TA
    Ho, LJ
    Cleutjens, CBJ
    Trapman, J
    Graham, FL
    Chung, LWK
    JOURNAL OF UROLOGY, 1998, 160 (01) : 220 - 229
  • [6] Cancer-specific activation of the survivin promoter and its potential use in gene therapy
    Jin-Shing Chen
    Jaw-Ching Liu
    Lei Shen
    Kung-Ming Rau
    Hsu-Ping Kuo
    Yan M Li
    Daren Shi
    Yung-Chie Lee
    King-Jen Chang
    Mien-Chie Hung
    Cancer Gene Therapy, 2004, 11 : 740 - 747
  • [7] Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells
    Shin, T
    Sumiyoshi, H
    Matsuo, N
    Satoh, F
    Nomura, Y
    Mimata, H
    Yoshioka, H
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 435 (02) : 291 - 302
  • [8] Cancer-specific activation of the survivin promoter and its potential use in gene therapy
    Chen, JS
    Liu, JC
    Shen, L
    Rau, KM
    Kuo, HP
    Li, YM
    Shi, D
    Lee, YC
    Chang, KJ
    Hung, MC
    CANCER GENE THERAPY, 2004, 11 (11) : 740 - 747
  • [9] Promoter Hypermethylation of the BRCA1 Gene as a Novel Biomarker for Prostate Cancer
    Saleem, Mohammed A.
    Mustafa, Mustafa S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [10] Gene therapy for prostate cancer; Development of tissue specific promoter-based gene therapy
    Gotoh, A
    Shirakawa, T
    Wada, Y
    Ko, SC
    Kao, CH
    Chung, LWK
    Kamidono, S
    FRONTIERS IN HUMAN GENETICS: DISEASES AND TECHNOLOGIES, 2001, : 363 - 376